Summit Therapeutics Inc. (SMMT) balance sheet
NASDAQ · Healthcare · Biotechnology · 265 employees · CEO Robert W. Duggan
- Price
- $16.03 -1.05%
- Market cap
- $12.8B
- Enterprise value
- $12.4B
- Last report
- Q2 '26 filed 2026-07-23
- Next report
- 2026-11-02 EPS est. -$0.28
At the end of Q2 '26 Summit Therapeutics Inc. (SMMT) held $691M in cash and short-term investments against $20.4M of debt incl. leases. Total assets $752M, total liabilities $122M, shareholders' equity $630M.
Balance sheet
| Balance sheet | Trend | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & equivalents | $33.2M | $19.6M | $56.5M | $48.8M | $22.5M | $71.5M | $83.8M | $164M | $219M | $167M | $80.8M | $419M | |
| Short-term investments | $136M | $144M | $90.9M | $76M | $235M | $300M | $246M | $116M | $0 | $362M | $373M | $271M | |
| Receivables | $3.64M | $667K | $671K | $753K | $753K | $504K | $445K | $0 | $0 | $0 | $0 | $0 | |
| Other current assets | $1.41M | $98.6K | $143K | $4.49M | $1.87M | $1.52M | $8.67M | $7.31M | $8.34M | $5.09M | $13.5M | $29.9M | |
| Current assets | $180M | $168M | $150M | $130M | $260M | $374M | $339M | $287M | $227M | $535M | $468M | $721M | |
| Property, plant & equipment (net) | $5.7M | $5.45M | $4.8M | $7.61M | $7.06M | $6.29M | $5.91M | $5.42M | $4.58M | $16.1M | $16M | $21.2M | |
| Goodwill | $1.49M | $1.49M | $1.5M | $1.49M | $1.49M | $1.52M | $1.49M | $1.49M | $1.5M | $1.49M | $1.49M | $1.97M | |
| Other non-current assets | $606K | $4.17M | $4.18M | $1.66M | $1.77M | $1.78M | $2.04M | $3.21M | $4.78M | $5.35M | $6.24M | $8.45M | |
| Non-current assets | $7.79M | $11.1M | $10.5M | $10.8M | $10.3M | $9.58M | $9.44M | $10.1M | $10.9M | $22.9M | $23.7M | $31.6M | |
| Total assets | $187M | $180M | $161M | $141M | $270M | $384M | $348M | $297M | $238M | $557M | $491M | $752M | |
| Liabilities | |||||||||||||
| Accounts payable | $779K | $2.72M | $2.11M | $5.08M | $2.64M | $2.48M | $3.7M | $3.87M | $16.9M | $15.1M | $20.9M | $22.9M | |
| Accrued expenses | $3.05M | $3M | $6.95M | $5.22M | $21.7M | $14.1M | $15.6M | $16.4M | $19.2M | $23.8M | $33.6M | $9.44M | |
| Short-term debt | $0 | $82.2M | $0 | $0 | $79M | $18.7M | $0 | $0 | $0 | $0 | $0 | $3.55M | |
| Other current liabilities | $3.27M | $3.28M | $4.86M | $5.43M | $4.49M | $6.86M | $11M | $3.99M | $5.93M | $12.8M | $6.23M | $2.62M | |
| Current liabilities | $9.42M | $93.5M | $16.1M | $18.7M | $111M | $45M | $33.3M | $27M | $44.3M | $54.2M | $63.1M | $104M | |
| Long-term debt | $78.9M | $0 | $79.1M | $79.7M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $16.8M | |
| Lease obligations (non-current) | $3.42M | $3.19M | $2.6M | $4.64M | $3.96M | $3.21M | $2.76M | $2.25M | $1.79M | $13M | $12.8M | $0 | |
| Other non-current liabilities | $1.19M | $1.21M | $1.24M | $2.64M | $1.26M | $1.31M | $1.3M | $1.32M | $1.35M | $1.36M | $1.36M | $1.8M | |
| Non-current liabilities | $83.6M | $4.4M | $83M | $86.9M | $5.22M | $4.52M | $4.06M | $3.57M | $3.14M | $14.3M | $14.1M | $18.6M | |
| Total liabilities | $93M | $97.9M | $99.1M | $106M | $116M | $49.5M | $37.4M | $30.6M | $47.4M | $68.5M | $77.3M | $122M | |
| Equity | |||||||||||||
| Common stock & paid-in capital | $5.51M | $5.74M | $5.55M | $5.59M | $5.72M | $5.62M | $5.89M | $5.74M | $5.45M | $5.75M | $5.88M | $7.93M | |
| Retained earnings | -$738M | -$786M | -$786M | -$826M | -$867M | -$880M | -$971M | -$989M | -$1.35B | -$1.7B | -$1.88B | -$2.7B | |
| Accumulated other comprehensive income | -$1.92M | -$1.91M | -$1.94M | -$1.95M | -$1.97M | -$1.76M | -$1.83M | -$1.99M | -$2.02M | -$1.89M | -$2M | -$2.67M | |
| Shareholders' equity | $94.4M | $81.7M | $61.5M | $35.2M | $154M | $334M | $311M | $267M | $190M | $489M | $414M | $630M | |
| Debt | |||||||||||||
| Total debt (incl. leases) | $84.7M | $87.7M | $84M | $87.3M | $85.9M | $24.8M | $5.77M | $5M | $4.07M | $15.5M | $15.2M | $20.4M | |
| Net debt (debt - cash) | $51.4M | $68.1M | $27.4M | $38.4M | $63.4M | -$46.7M | -$78M | -$159M | -$214M | -$152M | -$65.6M | -$399M | |
| Balance sheet | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & equivalents | $35.1M | $28.5M | $35.2M | $50M | $48.8M | $53.2M | $284M | $56.5M | $83.8M | $167M | |
| Short-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $90.9M | $246M | $362M | |
| Receivables | $0 | $0 | $12.5M | $318K | $7.48M | $12.7M | $4.98M | $671K | $445K | $0 | |
| Other current assets | $5.74M | $15.8M | $3.74M | $4.98M | $1.12M | $890K | $245M | $143K | $8.67M | $5.09M | |
| Current assets | $41.7M | $50.7M | $61.2M | $62.1M | $64.4M | $72.1M | $535M | $150M | $339M | $535M | |
| Property, plant & equipment (net) | $145K | $2.93M | $2.02M | $1.2M | $939K | $2.58M | $4.14M | $4.8M | $5.91M | $16.1M | |
| Goodwill | $830K | $3.51M | $2.38M | $1.15M | $1.49M | $1.49M | $1.47M | $1.5M | $1.49M | $1.49M | |
| Intangible assets | $4.34M | $20.9M | $13.9M | $7.71M | $8.46M | $7.71M | $0 | $0 | $0 | $0 | |
| Other non-current assets | $0 | -$1.42K | $0 | $3.27M | $0 | $126K | $470K | $4.18M | $2.04M | $5.35M | |
| Non-current assets | $5.31M | $27.4M | $18.3M | $13.3M | $10.9M | $11.9M | $6.08M | $10.5M | $9.44M | $22.9M | |
| Total assets | $47M | $78.1M | $79.5M | $75.5M | $75.3M | $84M | $541M | $161M | $348M | $557M | |
| Liabilities | |||||||||||
| Accounts payable | $1.13M | $12.5M | $5.8M | $3.38M | $4.51M | $3.24M | $289K | $2.11M | $3.7M | $15.1M | |
| Accrued expenses | $0 | $0 | $0 | $4.33M | $2.41M | $5.33M | $8.69M | $6.95M | $15.6M | $23.8M | |
| Short-term debt | $0 | $0 | $0 | -$1.01M | $0 | $0 | $16.1M | $0 | $0 | $0 | |
| Taxes payable | $117K | $232K | $249K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Deferred revenue | $0 | $0 | $0 | $1.17M | $6.15M | $5.88M | $0 | $0 | $0 | $0 | |
| Other current liabilities | $12.2M | $20M | $10.9M | $1.67M | $1.26M | $3.72M | $5.14M | $4.86M | $11M | $12.8M | |
| Current liabilities | $13.6M | $32.5M | $17.2M | $9.9M | $14.6M | $19M | $31.6M | $16.1M | $33.3M | $54.2M | |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $403M | $79.1M | $0 | $0 | |
| Lease obligations (non-current) | $0 | $0 | $0 | $330K | $55.1K | $1.25M | $2.25M | $2.6M | $2.76M | $13M | |
| Deferred revenue (non-current) | $29.5M | $38.6M | $1.09M | $386K | $418K | $0 | $0 | $0 | $0 | $0 | |
| Deferred tax liabilities | $706K | $3.37M | $2.2M | $1.61M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other non-current liabilities | $7.5M | $8.06M | $3.28M | $2.12M | $1.84M | $2.06M | $1.16M | $1.24M | $1.3M | $1.36M | |
| Non-current liabilities | $37.7M | $50M | $6.56M | $4.44M | $2.32M | $3.31M | $407M | $83M | $4.06M | $14.3M | |
| Total liabilities | $51.3M | $82.6M | $23.7M | $14.3M | $16.9M | $22.3M | $438M | $99.1M | $37.4M | $68.5M | |
| Equity | |||||||||||
| Common stock & paid-in capital | $772K | $1.04M | $2.1M | $507K | $607K | $726K | $1.72M | $5.55M | $5.89M | $5.75M | |
| Retained earnings | -$92.2M | -$133M | -$99.8M | -$119M | -$155M | -$222M | -$308M | -$786M | -$971M | -$1.7B | |
| Accumulated other comprehensive income | $0 | $0 | $0 | -$3.6M | -$2.79M | -$1.63M | -$1.54M | -$1.94M | -$1.83M | -$1.89M | |
| Shareholders' equity | -$4.37M | -$4.46M | $55.8M | $61.1M | $58.4M | $61.7M | $103M | $61.5M | $311M | $489M | |
| Debt | |||||||||||
| Total debt (incl. leases) | $0 | $0 | $0 | $700K | $342K | $2.06M | $423M | $84M | $5.77M | $15.5M | |
| Net debt (debt - cash) | -$35.1M | -$28.5M | -$35.2M | -$49.3M | -$48.4M | -$51.2M | $139M | $27.4M | -$78M | -$152M | |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Cash, investments and debt
quarter endsThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02